A significant reduction in seizure frequency and improvement in facial angiofibromas were observed during the follow-up period.<h4>Conclusion</h4>A heterozygous splicing mutation in the TSC2 gene was identified, confirming the diagnosis of familial TSC. This evidence concerns the gene TSC2 and tuberous sclerosis.